94 related articles for article (PubMed ID: 4371048)
1. [Cushing's disease and genesis of the adrenocorticotrophic hormone].
Stigliani R; Barbolini G; Storico I
Arch De Vecchi Anat Patol; 1973; 58(1-3):335-92. PubMed ID: 4371048
[No Abstract] [Full Text] [Related]
2. [Tumors of the hypophysis in Itsenko-Cushing disease].
Soskin LS; Burov IuS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(2):286-92. PubMed ID: 4306734
[No Abstract] [Full Text] [Related]
3. [Cushing's syndrome].
Shimizu N
Nihon Rinsho; 1972 Jul; 30(7):1481-4. PubMed ID: 4344778
[No Abstract] [Full Text] [Related]
4. [The functional state of the hypothalamo-hypophyseal-adrenal system in insulin hypoglycemia].
Pinchuk LM
Biull Eksp Biol Med; 1973 May; 75(5):27-9. PubMed ID: 4360360
[No Abstract] [Full Text] [Related]
5. [Pathological aspects of adrenalectomy in hypothalamic-pituitary Cushing's syndrome (author's transl)].
Kracht J; Bayer JM
Verh Dtsch Ges Pathol; 1972; 56():376-81. PubMed ID: 4130848
[No Abstract] [Full Text] [Related]
6. Ectopic adrenocorticotropin (ACTH) and corticotropin-releasing hormone (CRH) production in the adrenal gland: basic and clinical aspects.
Vrezas I; Willenberg HS; Mansmann G; Hiroi N; Fritzen R; Bornstein SR
Microsc Res Tech; 2003 Jun; 61(3):308-14. PubMed ID: 12768546
[TBL] [Abstract][Full Text] [Related]
7. A clinico-pathological study of two patients with Cushing's disease.
Croxson MS; Synek BJ
N Z Med J; 1980 Nov; 92(671):349-51. PubMed ID: 6256694
[TBL] [Abstract][Full Text] [Related]
8. [Hypothalamo-pituitary-adrenal cortex system and the glucocorticoid kinetics in Cushing's syndrome treated with chlodithane and large doses of reserpine].
Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Markov VV; Cheban AK
Ter Arkh; 1980; 52(7):124-8. PubMed ID: 6105729
[No Abstract] [Full Text] [Related]
9. Cushing's syndrome with dual pituitary-adrenal control.
Choi Y; Werk EE; Sholiton LJ
Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
[No Abstract] [Full Text] [Related]
10. [Adrenal pathology of Cushing's syndrome in children and juveniles (author's transl)].
Kracht J
Verh Dtsch Ges Pathol; 1971; 55():142-6. PubMed ID: 4130707
[No Abstract] [Full Text] [Related]
11. [Cushing's syndrome; optimalization of the diagnosis].
de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1449-54. PubMed ID: 8766769
[No Abstract] [Full Text] [Related]
12. [Functional exploration of the adrenal gland activity in the hypothalamo-hypophyseal-adrenal axis].
Kehyayan E
Minerva Pediatr; 1976 Jun; 28(21):1330-3. PubMed ID: 181665
[No Abstract] [Full Text] [Related]
13. Patterns of corticotropic cells in the adult human pituitary in Cushing's disease.
McNicol AM
Diagn Histopathol; 1981; 4(4):335-41. PubMed ID: 6279372
[TBL] [Abstract][Full Text] [Related]
14. Unilateral adrenal hypertrophy in ectopic ACTH syndrome.
Sigman LM; Wallach L
Arch Intern Med; 1984 Sep; 144(9):1869-70. PubMed ID: 6089683
[TBL] [Abstract][Full Text] [Related]
15. THE EFFECT OF ADRENOCORTICOTROPHIC HORMONE IN CONGENITAL ADRENAL HYPERPLASIA WITH VIRILISM AND IN CUSHING'S SYNDROME TREATED WITH METHYL TESTOSTERONE.
Lewis RA; Wilkins L
J Clin Invest; 1949 Mar; 28(2):394-400. PubMed ID: 16695689
[No Abstract] [Full Text] [Related]
16. Immunohistological studies on Crooke cells.
Kracht J; Hachmeister U
Endokrinologie; 1967 May; 51(3):164-9. PubMed ID: 4384342
[No Abstract] [Full Text] [Related]
17. ACTH independent Cushing's disease.
Lindholm J; Christensen L; Therkildsen MH
J Endocrinol Invest; 1990 May; 13(5):433-4. PubMed ID: 2166104
[No Abstract] [Full Text] [Related]
18. Cushing's Syndrome.
Pivonello R; De Martino MC; De Leo M; Lombardi G; Colao A
Endocrinol Metab Clin North Am; 2008 Mar; 37(1):135-49, ix. PubMed ID: 18226734
[TBL] [Abstract][Full Text] [Related]
19. Visual vignette. Cushing's syndrome due to ectopic production of ACTH by a bronchial carcinoid.
Szymajda A; Eledrisi MS; Lieberman S; Belalcazar LM; Schnadig V
Endocr Pract; 2001; 7(6):492. PubMed ID: 11770489
[No Abstract] [Full Text] [Related]
20. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
